Skip to main content
Surname
Woodcock
Disclosure of interest

I, Ashley Woodcock, residing in United Kingdom, appointed to the Technology and Economic Assessment Panel, co-chair of the Decision XXXI/7 Task Force on the continued provision of information on energy efficient and low-global warming technologies, and member of the Decision XXXI-1TEAP Task Force on Replenishment of the Multilateral Fund: declare as follows,

1) I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.

2) I am a Consultant Respiratory Physician and Professor of Respiratory Medicine.

3) This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines.  I understand that this written agreement is a condition of my service.

4) My interests, and those of my personal partner and dependents include the following:  I am a member of the NW Lung Centre Charity and Chairman of its subsidiary Medicines Evaluation Unit. I am Chairman of Axalbion which is developing a new oral cough medicine (in Phase 1). I am Chairman of Reacta which is developing diagnostic tests for Food Allergy. None of these have any interest in relation to the Montreal Protocol, TEAP, MCTOC, or its Task Forces.

  • Proprietary interests: I do not have proprietary interest in the subject matter of the Montreal Protocol, TEAP, MCTOC, or any Task Force.
  • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the Montreal Protocol, TEAP, MCTOC, or any Task Force.
  • Employment, consultancy, directorship or other positions:  I occasionally consult on new medicines for pharmaceutical companies. None of these interests have any relation to the Montreal Protocol, TEAP, MCTOC, or any Task Force.
  • Government advice and other policy development: I am on an advisory panel on the phase down of HFC inhalers for UK NHS Sustainability, and am Clinical Sustainability Lead for the Manchester University NHS Foundation Trust and associated hospitals.  No other relevant activity
  • Paid research activities, fellowships or grants: None relevant
  • Other interests: None relevant

5) The source of funding for my participation in the work of TEAP is Manchester University NHS Foundation NHS Trust, which allows me to take leave and provides travel support to attend meetings

6)   Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines. 

7)   I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.

8)   I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.

9)   I understand that this DOI will expire no later than one year after I have signed it.

Signed: Ashley Woodcock
Jan 1 2021

Assessment panel/TOC membership
Membership
Membership Designation
Membership Designation
Membership
Membership Designation
Membership Designation
Year
2019
2021